Georgia Bio Deals of the Year Spotlight Financings, Acquisitions and IPO
Global Biochips Market Anticipated to Reach $17 Billion by 2022: Growth in Personalized Medicine - Research and Markets
Global Veterinary Laboratory Testing Services Market Briefing 2017 - Research and Markets
A group of top managers continue to keep looking for good investment opportunities, while taking full advantage of a rising (and potentially overvalued) market to book some gains.
Get our sector-by-sector take on the bond market, plus our five best bond ideas.
Continued technology advancements and market expansion support Illumina's narrow moat.
Top managers continue to exercise a lot of patience as they look for buying opportunities in a U.S. equity market that has risen close to 40% since the start of 2013.
While a majority of our top fund managers are outperforming this year, three of them truly stand out from the rest given their ability to outperform the market over all time periods.
Widening investment-grade credit spreads and rising interest rates lead to losses.